I have heard that from some patients, typically in calls or emails: they have noticed reduced drinking and/or smoking after starting a GLP-1 receptor agonist, Leggio says
youre protecting the validity and potential of your own hard work
Blue Cross and BCN will continue covering GLP-1s prescribed to treat Type 2 diabetes, including the medications Ozempic, Mounjaro, Rybelsus and Victoza
Every intake is reviewed by a board-certified DO before anything is prescribed, and the name of the provider who signed off is sent to the patient
You should be able to get a prescription for semaglutide if you meet the following criteria: a BMI of at least 27 or higher, with one weight-related medical issue like type 2 diabetes or high cholesterol, or simply a BMI of 30 or above
Theoretical efficacy drops slightly to around 90%, though this has never been validated in clinical trials